{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:29Z","timestamp":1760955389238},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The clinical course of Cystic Fibrosis (CF) is usually measured using the percent predicted FEV<jats:sub>1<\/jats:sub> and BMI Z-score referenced against a healthy population, since achieving normality is the ultimate goal of CF care. Referencing against age and sex matched CF peers may provide valuable information for patients and for comparison between CF centers or populations. Here, we used a large database of European CF patients to compute CF specific reference equations for FEV<jats:sub>1<\/jats:sub> and BMI, derived CF-specific percentile charts and compared these European data to their nearest international equivalents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>34859 FEV<jats:sub>1<\/jats:sub> and 40947 BMI observations were used to compute European CF specific percentiles. Quantile regression was applied to raw measurements as a function of sex, age and height. Results were compared with the North American equivalent for FEV<jats:sub>1<\/jats:sub> and with the WHO 2007 normative values for BMI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>FEV<jats:sub>1<\/jats:sub> and BMI percentiles illustrated the large variability between CF patients receiving the best current care. The European CF specific percentiles for FEV<jats:sub>1<\/jats:sub> were significantly different from those in the USA from an earlier era, with higher lung function in Europe. The CF specific percentiles for BMI declined relative to the WHO standard in older children. Lung function and BMI were similar in the two largest contributing European Countries (France and Germany).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The CF specific percentile approach applied to FEV<jats:sub>\n                <jats:bold>1<\/jats:bold>\n              <\/jats:sub> and BMI allows referencing patients with respect to their peers. These data allow peer to peer and population comparisons in CF patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1172-7-64","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T14:14:43Z","timestamp":1347027283000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis"],"prefix":"10.1186","volume":"7","author":[{"given":"Pierre-Yves","family":"Bo\u00eblle","sequence":"first","affiliation":[]},{"given":"Laura","family":"Viviani","sequence":"additional","affiliation":[]},{"given":"Pierre-Francois","family":"Busson","sequence":"additional","affiliation":[]},{"given":"Hanne V","family":"Olesen","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Ravilly","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Stern","sequence":"additional","affiliation":[]},{"given":"Baroukh M","family":"Assael","sequence":"additional","affiliation":[]},{"given":"Celeste","family":"Barreto","sequence":"additional","affiliation":[]},{"given":"Pavel","family":"Drevinek","sequence":"additional","affiliation":[]},{"given":"Muriel","family":"Thomas","sequence":"additional","affiliation":[]},{"given":"Uros","family":"Krivec","sequence":"additional","affiliation":[]},{"given":"Meir","family":"Mei-Zahav","sequence":"additional","affiliation":[]},{"given":"Jean-Fran\u00e7ois","family":"Vibert","sequence":"additional","affiliation":[]},{"given":"Annick","family":"Clement","sequence":"additional","affiliation":[]},{"given":"Anil","family":"Mehta","sequence":"additional","affiliation":[]},{"given":"Harriet","family":"Corvol","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,9,7]]},"reference":[{"key":"468_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/adc.77.6.493","volume":"77","author":"JA Dodge","year":"1997","unstructured":"Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT: Incidence, population, and survival of cystic fibrosis in the uk, 1968-95. uk cystic fibrosis survey management committee. Arch Dis Child. 1997, 77: 493-496. 10.1136\/adc.77.6.493.","journal-title":"Arch Dis Child"},{"issue":"Suppl 2","key":"468_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jcf.2010.08.002","volume":"9","author":"G Mehta","year":"2010","unstructured":"Mehta G, Macek M Jr, Mehta A: Cystic fibrosis across europe: eurocarecf analysis of demographic data from 35 countries. J Cyst Fibros. 2010, 9 (Suppl 2): S5-S21.","journal-title":"J Cyst Fibros"},{"key":"468_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(09)62161-9","volume":"375","author":"J McCormick","year":"2010","unstructured":"McCormick J, Mehta G, Olesen HV, Viviani L, Macek M Jr, Mehta A: Comparative demographics of the european cystic fibrosis population: a cross-sectional database analysis. Lancet. 2010, 375: 1007-1013. 10.1016\/S0140-6736(09)62161-9.","journal-title":"Lancet"},{"key":"468_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159: 179-187.","journal-title":"Am J Respir Crit Care Med"},{"key":"468_CR5","first-page":"725","volume":"127","author":"RJ Knudson","year":"1983","unstructured":"Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B: Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983, 127: 725-734.","journal-title":"Am Rev Respir Dis"},{"key":"468_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jpeds.2005.06.003","volume":"147","author":"D Kastner-Cole","year":"2005","unstructured":"Kastner-Cole D, Palmer CN, Ogston SA, Mehta A, Mukhopadhyay S: Overweight and obesity in deltaF508 homozygous cystic fibrosis. J Pediatr. 2005, 147: 402-404. 10.1016\/j.jpeds.2005.06.003.","journal-title":"J Pediatr"},{"key":"468_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF00972175","volume":"5","author":"DJ Matthew","year":"1977","unstructured":"Matthew DJ, Warner JO, Chrispin AR, Norman AP: The relationship between chest radiographic scores and respiratory function tests in children with cystic fibrosis. Pediatr Radiol. 1977, 5: 198-200. 10.1007\/BF00972175.","journal-title":"Pediatr Radiol"},{"key":"468_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1164\/rccm.200410-1335OC","volume":"172","author":"M Kulich","year":"2005","unstructured":"Kulich M, Rosenfeld M, Campbell J, Kronmal R, Gibson RL, Goss CH, Ramsey B: Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2005, 172: 885-891. 10.1164\/rccm.200410-1335OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"468_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.crad.2006.09.011","volume":"62","author":"J McCormick","year":"2007","unstructured":"McCormick J, Conway SP, Mehta A: Paediatric northern score centile charts for the chest radiograph in cystic fibrosis. Clin Radiol. 2007, 62: 78-81. 10.1016\/j.crad.2006.09.011.","journal-title":"Clin Radiol"},{"key":"468_CR10","unstructured":"ECFS: ECFS Patient Registry. http:\/\/www.ecfs.eu\/projects\/ecfs-patient-registry\/intro"},{"key":"468_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","volume":"7","author":"PM Farrell","year":"2008","unstructured":"Farrell PM: The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008, 7: 450-453. 10.1016\/j.jcf.2008.03.007.","journal-title":"J Cyst Fibros"},{"key":"468_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MPG.0b013e3181a3bfdd","volume":"50","author":"O Efrati","year":"2010","unstructured":"Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J: Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the israeli multicenter study. J Pediatr Gastroenterol Nutr. 2010, 50: 173-178. 10.1097\/MPG.0b013e3181a3bfdd.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"468_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J: Development of a WHO growth reference for school-aged children and adolescents. Bulletin of the World Health Organization. 2007, 85: 660-667. 10.2471\/BLT.07.043497.","journal-title":"Bulletin of the World Health Organization"},{"key":"468_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/sim.2271","volume":"25","author":"Y Wei","year":"2006","unstructured":"Wei Y, Pere A, Koenker R, He X: Quantile regression methods for reference growth charts. Stat Med. 2006, 25: 1369-1382. 10.1002\/sim.2271.","journal-title":"Stat Med"},{"key":"468_CR15","first-page":"797","volume":"67","author":"G Lucotte","year":"1995","unstructured":"Lucotte G, Hazout S, De Braekeleer M: Complete map of cystic fibrosis mutation DF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease. Hum Biol. 1995, 67: 797-803.","journal-title":"Hum Biol"},{"key":"468_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J: Development of a who growth reference for school-aged children and adolescents. Bull World Health Organ. 2007, 85: 660-667. 10.2471\/BLT.07.043497.","journal-title":"Bull World Health Organ"},{"key":"468_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jcf.2011.09.006","volume":"11","author":"H Corvol","year":"2012","unstructured":"Corvol H, Beucher J, Boelle PY, Busson PF, Muselet-Charlier C, Clement A, Ratjen F, Grasemann H, Laki J, Palmer CN: Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. J Cyst Fibros. 2012, 11: 63-67. 10.1016\/j.jcf.2011.09.006.","journal-title":"J Cyst Fibros"},{"key":"468_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ppul.21456","volume":"46","author":"C Taylor","year":"2011","unstructured":"Taylor C, Commander CW, Collaco JM, Strug LJ, Li W, Wright FA, Webel AD, Pace RG, Stonebraker JR, Naughton K, et al: A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies. Pediatr Pulmonol. 2011, 46: 857-869. 10.1002\/ppul.21456.","journal-title":"Pediatr Pulmonol"},{"key":"468_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","volume":"365","author":"BW Ramsey","year":"2011","unstructured":"Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevinek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al: A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011, 365: 1663-1672. 10.1056\/NEJMoa1105185.","journal-title":"N Engl J Med"},{"key":"468_CR20","first-page":"1","volume-title":"Registre Fran\u00e7ais de la Mucoviscidose","author":"Vaincre-la-Mucoviscidose, Ined","year":"2011","unstructured":"Vaincre-la-Mucoviscidose, Ined: Bilan des donn\u00e9es 2008. Registre Fran\u00e7ais de la Mucoviscidose. 2011, 1-20."},{"key":"468_CR21","first-page":"1","volume-title":"Patient Registry","author":"Cystic Fibrosis Foundation","year":"2009","unstructured":"Cystic Fibrosis Foundation: 2009 Annual Data Report. Patient Registry. 2009, 1-28."},{"key":"468_CR22","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","volume":"183","author":"M Cohen-Cymberknoh","year":"2011","unstructured":"Cohen-Cymberknoh M, Shoseyov D, Kerem E: Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med. 2011, 183: 1463-1471. 10.1164\/rccm.201009-1478CI.","journal-title":"Am J Respir Crit Care Med"},{"key":"468_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.mcp.0000183051.18611.e4","volume":"11","author":"LJ Stark","year":"2005","unstructured":"Stark LJ, Powers SW: Behavioral aspects of nutrition in children with cystic fibrosis. Curr Opin Pulm Med. 2005, 11: 539-542. 10.1097\/01.mcp.0000183051.18611.e4.","journal-title":"Curr Opin Pulm Med"},{"key":"468_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jpeds.2007.10.021","volume":"152","author":"A Magoffin","year":"2008","unstructured":"Magoffin A, Allen JR, McCauley J, Gruca MA, Peat J, Van Asperen P, Gaskin K: Longitudinal analysis of resting energy expenditure in patients with cystic fibrosis. J Pediatr. 2008, 152: 703-708. 10.1016\/j.jpeds.2007.10.021.","journal-title":"J Pediatr"},{"key":"468_CR25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.pcl.2009.06.008","volume":"56","author":"SH Michel","year":"2009","unstructured":"Michel SH, Maqbool A, Hanna MD, Mascarenhas M: Nutrition management of pediatric patients who have cystic fibrosis. Pediatr Clin North Am. 2009, 56: 1123-1141. 10.1016\/j.pcl.2009.06.008.","journal-title":"Pediatr Clin North Am"},{"key":"468_CR26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/oxfordjournals.aje.a009172","volume":"145","author":"M Rosenfeld","year":"1997","unstructured":"Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B: Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997, 145: 794-803. 10.1093\/oxfordjournals.aje.a009172.","journal-title":"Am J Epidemiol"},{"key":"468_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1067\/mpd.2000.107891","volume":"137","author":"BS Zemel","year":"2000","unstructured":"Zemel BS, Jawad AF, FitzSimmons S, Stallings VA: Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr. 2000, 137: 374-380. 10.1067\/mpd.2000.107891.","journal-title":"J Pediatr"},{"key":"468_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcf.2005.01.001","volume":"4","author":"J McCormick","year":"2005","unstructured":"McCormick J, Sims EJ, Green MW, Mehta G, Culross F, Mehta A: Comparative analysis of cystic fibrosis registry data from the uk with usa, france and australasia. J Cyst Fibros. 2005, 4: 115-122. 10.1016\/j.jcf.2005.01.001.","journal-title":"J Cyst Fibros"},{"key":"468_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jcf.2008.06.003","volume":"7","author":"ME Hodson","year":"2008","unstructured":"Hodson ME, Simmonds NJ, Warwick WJ, Tullis E, Castellani C, Assael B, Dodge JA, Corey M: An international\/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. J Cyst Fibros. 2008, 7: 537-542. 10.1016\/j.jcf.2008.06.003.","journal-title":"J Cyst Fibros"},{"key":"468_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ng.838","volume":"43","author":"FA Wright","year":"2011","unstructured":"Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L, Berthiaume Y, Cutler D, Cojocaru A, Collaco JM, et al: Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet. 2011, 43: 539-546. 10.1038\/ng.838.","journal-title":"Nat Genet"},{"key":"468_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-7-40","volume":"7","author":"N Nathan","year":"2012","unstructured":"Nathan N, Abou Taam R, Epaud R, Delacourt C, Deschildre A, Reix P, Chiron R, de Pontbriand U, Brouard J, Fayon M: A national internet-linked based database for pediatric interstitial lung diseases: the French network. Orphanet J Rare Dis. 2012, 7: 40-10.1186\/1750-1172-7-40.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-7-64.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:42:40Z","timestamp":1630528960000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-7-64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-7-64","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,7]]},"assertion":[{"value":"6 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"64"}}